ArticleNeurochemical research2026
The Molecular Signature of Astrocyte Response to Hypoxia Outlines the Metabolic and Cell Survival Mechanisms for Neuroprotection.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The molecular reprogramming of astrocyte gene expression induced by oxygen deprivation is one of the astrocyte-mediated neuroprotective processes relevant to neurodegenerative diseases and various brain injury conditions. The primary oxygen sensor that mediates eukaryotic cells' adaptive response to changes in oxygen concentration is hypoxia-inducible transcription factor 1 alpha (HIF-1α). Therefore, the astrocyte neuroprotective ability triggered by the activation of HIF-1α downstream effectors has sparked interest in hypoxia mimetics-based treatment approaches as a means to induce adaptive responses without direct hypoxia exposure. Compared to similar studies that evaluated the effect of both oxygen and glucose deprivation for several hours, this study uncovers the reprogramming of astrocyte gene expression patterns after exposure to hypoxia alone for short and relatively long periods of time - 30 min for short-term (ST) and three hours for long-term (LT) hypoxia - as well as following 24 h of reoxygenation induced recovery (RIR). The transcriptional activation of a number of genes, including Pdk1, Mct4, Sirt1, Bcl2, Hsp70, and Sod2, ends rather rapidly, only lasting over the ST-hypoxia. Conversely, during LT-hypoxia, Glut1 and Vegf1 show elevated expression, which is likely due to a positive feedback loop in which secreted Vegf increases both its own and Glut1's expression. Interestingly, the ST-hypoxia establishes long-lasting variations of gene expression that may be essential for generating an effective neuroprotective response. This is demonstrated by the fact that Mct4 expression continues to be raised during the 24-hour normoxia period that follows the ST-hypoxia, thereby aiding in metabolic adaptation. Therefore, it is reasonable to draw the conclusion that the length of transcriptional activation varies depending on the gene and is associated with the function of the encoded protein.
Indexed as
Identifiers
41533048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.